Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT05762471 · COMPLETED
Trial details
- NCT number
- NCT05762471
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2024-04-11
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.